首页> 外文OA文献 >Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies

【2h】

Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies

机译：通过抗叶酸受体抗体的细胞内表达逆转卵巢癌细胞转化表型

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
M Figini; R Ferri; D Mezzanzanica; M Bagnoli; E Luison; S Miotti; S Canevari;
展开▼
作者单位

展开▼
年度 2003
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies. [J] . Figini M, Ferri R, Mezzanzanica D, Gene therapy . 2003,第12期

机译：通过抗叶酸受体抗体的细胞内表达逆转卵巢癌细胞中转化的表型。
2. Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine [J] . Lainie P. Martin, Jason A. Konner, Kathleen N. Moore, Gynecologic Oncology: An International Journal . 2017,第2期

机译：复发上皮卵巢癌患者归档肿瘤和活检样品中叶酸受体α（FRα）表达的表征：FRα靶向抗体 - 药物共轭米尔韦妥昔单抗索拉斯综合症的展开研究
3. Expression of an Ovarian Cancer Anti-Idiotype Antibody (6B11VLVHCH3) in Chinese Hamster Ovary (CHO) Cells with Improved Immunoactivity and Stability Over Proteins Expressed in Prokaryotic Cells. [J] . Shi J, Chang X, Feng J, Hybridoma . 2007,第5期

机译：卵巢癌抗独特型抗体（6B11VLVHCH3）在中国仓鼠卵巢（CHO）细胞中的表达具有比原核细胞中表达的蛋白质更高的免疫活性和稳定性。
4. Internalization of Folate Receptor Targeting Nanoparticles into Ovarian Cancer Cell Lines [C] . Katherine Haddad, Tram Le, Handan Acar Society for Biomaterials annual meeting and exposition . 2019

机译：叶酸受体靶向纳米粒子的内在化成卵巢癌细胞系。
5. Receptor tyrosine kinase-like orphan receptor-1 (ROR1) expression in breast cancer stem cells can be targeted for anti-cancer-stem-cell therapy [D] . Liu, Grace. 2015

机译：乳腺癌干细胞中受体酪氨酸激酶样孤儿受体1（ROR1）的表达可用于抗癌干细胞治疗
6. OVARIAN CANCER SUICIDE GENE THERAPY WITH GENETICALLY ENGINEERED TRANSGENICALLY EXPRESSED INTRACELLULAR scFv ANTIBODIES AGAINST ANTI-OXIDATIVE ENZYMES [O] . Marek Malecki, Raf Malecki -1

机译：遗传修饰转基因表达的细胞内scFv抗体对抗氧化酶的卵巢癌自杀基因治疗
7. 138 Phase 1 dose-escalation study of STRO-002, an anti-folate receptor alpha (FRα) antibody drug conjugate (ADC), in patients with advanced platinum-resistant/refractory epithelial ovarian cancer (OC) [O] . R Naumann, F Braiteh, J Diaz, 2020

机译：138阶段1剂量 - 抗叶酸受体α（FRα）抗体药物缀合物（ADC）的抗叶酸受体α（FRα）抗体药物缀合物（ADC），抑制铂抗性/难治性上皮卵巢癌（OC）
8. Novel Anti-Beta2-Microglobulin Antibody Inhibition of Androgen Receptor Expression, Survival, and Progression in Prostate Cancer Cells. [R] . W. Huang 2012

机译：新型抗β2-微球蛋白抗体抑制前列腺癌细胞中雄激素受体的表达，存活和进展。

Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies

著录项

引文网络

相似文献

相关主题

期刊订阅